mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.055 |
0.4 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
Gefitinib |
FIMM |
pan-cancer |
AAC |
-0.15 |
0.4 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
Cyclopamine |
FIMM |
pan-cancer |
AAC |
-0.14 |
0.4 |